This report outlines the economic effects of asynchronous regulatory approvals for biotech-improved crops across major global commodity-exporting and -importing countries. Drawing on academic research using varied modeling and analytical techniques, it examines concrete impacts on trade flows, downstream processing industries, biotechnology adoption rates, R&D investment, crop breeding, and farm income. It also discusses proposed policies to reduce regulatory asynchrony and its consequences for producers and consumers in the global agricultural economy.